gefitinib has been researched along with stearic acid in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (stearic acid) | Trials (stearic acid) | Recent Studies (post-2010) (stearic acid) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 2,532 | 69 | 940 |
| Protein | Taxonomy | gefitinib (IC50) | stearic acid (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 7.5 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DR; Pawar, AA; Venkataraman, C | 1 |
1 other study(ies) available for gefitinib and stearic acid
| Article | Year |
|---|---|
Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.
Topics: Acetates; Aerosols; Antineoplastic Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chloroform; Crystallization; Crystallography, X-Ray; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Gefitinib; Hydrogen-Ion Concentration; Kinetics; Methylene Chloride; Microscopy, Electron, Transmission; Nanoparticles; Nanotechnology; Particle Size; Quinazolines; Solubility; Solvents; Stearic Acids; Technology, Pharmaceutical; Vapor Pressure | 2012 |